| 2023年年报 | 2023年中报 | 2022年年报 | 2022年中报 | |
|---|---|---|---|---|
| 营业收入(元) | ||||
| 制剂药销售(元) | 3,408,377,279.45 | 1,956,757,186.13 | 3,593,396,623.05 | 1,738,873,760.54 |
| 原料药(元) | 1,296,126,045.38 | 742,930,247.28 | 1,470,117,086.60 | 850,648,398.42 |
| 其他主营业务(元) | - | - | - | 1,830,502,032.37 |
| 其他(元) | 3,538,671,696.83 | 1,806,698,401.19 | 3,745,428,919.17 | 1,830,502,032.37 |
| 营业成本(元) | ||||
| 制剂药销售(元) | 1,261,112,304.74 | 655,936,129.61 | 1,369,102,993.30 | 641,533,975.89 |
| 原料药(元) | 443,382,671.96 | 282,881,564.54 | 653,866,318.89 | 421,957,781.55 |
| 其他主营业务(元) | - | - | - | 1,648,832,852.53 |
| 其他(元) | 3,185,700,611.20 | 1,631,598,719.26 | 3,354,424,285.08 | 1,648,832,852.53 |
| 毛利(元) | ||||
| 制剂药销售(元) | 2,147,264,974.71 | 1,300,821,056.52 | 2,224,293,629.75 | 1,097,339,784.65 |
| 原料药(元) | 852,743,373.42 | 460,048,682.74 | 816,250,767.71 | 428,690,616.87 |
| 其他主营业务(元) | - | - | - | 181,669,179.84 |
| 其他(元) | 352,971,085.63 | 175,099,681.93 | 391,004,634.09 | 181,669,179.84 |
| 毛利率(%) | ||||
| 制剂药销售(%) | 63.00 | 66.48 | 61.90 | 63.11 |
| 原料药(%) | 65.79 | 61.92 | 55.52 | 50.40 |
| 其他主营业务(%) | - | - | - | 9.92 |
| 其他(%) | 9.97 | 9.69 | 10.44 | 9.92 |
| 收入构成(%) | ||||
| 制剂药销售(%) | 41.35 | 43.42 | 40.79 | 27.82 |
| 原料药(%) | 15.72 | 16.49 | 16.69 | 13.61 |
| 其他主营业务(%) | - | - | - | 29.29 |
| 其他(%) | 42.93 | 40.09 | 42.52 | 29.29 |
| 毛利构成(%) | ||||
| 制剂药销售(%) | 64.04 | 67.19 | 64.82 | 58.08 |
| 原料药(%) | 25.43 | 23.76 | 23.79 | 22.69 |
| 其他主营业务(%) | - | - | - | 9.62 |
| 其他(%) | 10.53 | 9.04 | 11.39 | 9.62 |